Tracheobronchomalacia (TBM) is a rare disease caused by weakness of the trachea and bronchi due to softening of the supporting cartilage and hypotonia of myoelastic elements. 1, 2 We present two cases of TBM that were diagnosed after allogeneic BMT.
The first case was that of a 56-year-old male myelodysplastic syndrome patient who underwent BMT from an unrelated, HLAmatched donor in March 2008. After tapering of tacrolimus, extensive chronic GVHD (cGVHD) developed in November 2008 and resolved by January 2009 with the administration of prednisolone (PSL) and tacrolimus. In April 2009, the patient developed a cough and complained of dyspnoea on exertion. There were no abnormal findings on X-ray or computed tomography (CT) examinations of the chest. The dyspnoea reported by the patient worsened, and the level of the forced expiratory volume in 1 s divided by the forced vital capacity (FEV 1 /FVC%) fell to 43.2% (Supplementary Figure 1) . The residual lung volume increased to 147%, in contrast with 74.3% observed in November 2007. He was diagnosed with bronchiolitis obliterans (BO) without performing an additional high-resolution CT (HRCT) scan because his pulmonary function tests (PFTs) revealed obvious airway obstruction with a residual volume 4120%, and his chest CT scan did not indicate any respiratory infection or cryptogenic organising pneumonia. Treatment with inhaled budesonide and salmeterol, oral PSL and tacrolimus improved his symptoms; however, the symptoms did not resolve.
In May 2010, the patient was admitted to our hospital for a complete medical examination to ascertain the cause of his continuing cough and dyspnoea. A chest CT scan with inspiration was normal; however, an expiratory CT scan indicated a collapsed trachea with a 70% reduction in the cross-sectional area (CSA) of the trachea relative to inspiration (Figure 1a ). An HRCT scan did not show air trapping or thickness of the small airways. The spirogram revealed notching, which signifies a sudden diminution of flow at the beginning of expiration concomitant with airway collapse (Figure 2 ). The bronchoscopic examination revealed dynamic tracheal and bronchial collapse with expiratory effort (Figure 1b) , and a lung biopsy showed no evidence of BO. The patient was ultimately diagnosed with TBM rather than BO. Dyspnoea in the patient was stable because of the continuous treatment; however, the PFT and CT scan findings worsened slightly during the tapering of tacrolimus.
The second case was that of a 57-year-old female who received BMT for ALL from one HLA-DR antigen-mismatched, unrelated donor in December 2005. De novo cGVHD developed after tapering of tacrolimus and improved with readministration. In May 2011, the patient complained of dyspnoea upon exertion. Her expiratory CT scan revealed a 450% reduction in the CSA of the trachea with expiration and fibrotic changes (Figure 1c) . However, her PFTs indicated a moderate restrictive defect concealing the notch in the flow-volume loop. She started treatment with systemic PSL for late-onset, non-infectious pulmonary complications, and her trachea collapse was somewhat improved on a follow-up CT scan. TBM is a rare and serious complication in patients with various pulmonary conditions, including the following: long-term tracheal intubation, chronic obstructive pulmonary disease (COPD), smoking, chest trauma and lung surgery. [1] [2] [3] [4] The aetiology and histopathological characteristics of TBM are unclear. The diagnostic criterion for TBM is a ⩾ 50% reduction in the CSA of the trachea with expiration compared with inspiration on CT scan and/or bronchoscopy. [1] [2] [3] [4] [5] [6] [7] Expiratory phase Inspiratory phase Figure 1 . CT scans and a bronchoscopy in patients with TBM at the time of diagnosis. CT scans revealed narrowing of the airway lumen during the end-expiratory phase in case 1 (a) and case 2 (c). Moreover, a bronchoscopy in case 1 identified dynamic airway narrowing with expiration (b).
The signs and symptoms of TBM are nonspecific. Airway obstruction due to TBM causes dyspnoea, cough and wheezing, which are observed in other respiratory diseases as well, including BO, one of the most frequent complications after allogeneic BMT. The notching of the flow-volume loop in TBM reflects a sudden diminution of airflow at the beginning of expiration; however, TBM presentation is similar to BO with respect to decreased FEV 1 /FVC%. [1] [2] [3] [4] CT scans and bronchoscopy are useful for distinguishing TBM from BO. A CT scan in cases of TBM shows airway collapse at the end-expiratory phase, which contrasts with the bronchial dilation, brochiolectasis and air trapping observed in BO. In addition, bronchoscopy shows dynamic airway narrowing during the expiratory period in TBM, but shows no significant changes in BO.
Our patients did not present with histories of long-term tracheal intubation, COPD or lung surgery before or after BMT. They are ex-smokers; however, neither patient had a history of respiratory disease or abnormal findings in their PFTs before BMT. Because the symptoms and signs of TBM appeared after cGVHD developed, we hypothesised that cGVHD caused TBM. Pathogenic aspects of cGVHD resemble autoimmune diseases, particularly connective tissue diseases. 8 Relapsing polychondritis, an autoimmune connective tissue disease, has been reported to cause TBM. 9 Although chondritis associated with cGVHD has not been reported, cGVHD could potentially cause chondritis. 10 The first case was misdiagnosed as BO. Among the patients who are diagnosed with BO after BMT, some patients may have TBM. Our experience raised the possibility that TBM could occur as a result of cGVHD. If patients show signs or symptoms of respiratory tract disease after cGVHD, TBM should be considered as a diagnosis, and a dynamic CT scan or bronchoscopy should be performed during the end-expiratory phase to identify TBM cases. We discovered the second case of TBM through close observation of the CT scan results. The occurrence of two cases of TBM in a single institution raises the possibility that TBM cases are being overlooked. Volume (L) Figure 2 . Comparison of the spirograms before and after BMT in case 1. The flow-volume loop was normal before BMT (a). The flow-volume loop showed a low peak flow rate at the time the patient began experiencing dyspnoea (b) and typical notching from a rapid decrease in flow at the time the patient was diagnosed with TBM (c).
